Stay updated on Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Sign up to get notified when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The date for an event has been updated from May 9, 2025, to June 22, 2025.
    Difference
    0.6%
    Check dated 2025-06-27T00:41:54.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    4%
    Check dated 2025-06-19T20:01:19.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T11:20:53.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T06:07:57.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The date has been updated from May 4, 2025, to May 9, 2025.
    Difference
    0.3%
    Check dated 2025-05-14T23:39:01.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The date for an event has been updated from April 20, 2025, to May 4, 2025.
    Difference
    0.3%
    Check dated 2025-05-07T19:46:02.000Z thumbnail image

Stay in the know with updates to Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.